Hemorrhoids
Conditions
Keywords
hemorrhoids, laser, sclerotherapy
Brief summary
Patients with hemorrhoids 2-3 st will be treated with laser 1940nm or sclerothearapy with Aethoxysklerol
Detailed description
Prospective randomized, control study. Patients with hemorrhoids 2-3 will be randomized in two groups. 100 patient in each. Patients will be treated with laser 1940nm or sclerothearapy with Aethoxysklerol. Follow up for one year. Primary end point - recurrence of hemorrhoids desease.
Interventions
PROCEDURElaser procedure
In modified litothomy position patients with hemorrhoidal deasease will be treated with transcutaneous laser 1940nm 3watt in impulse regimen
PROCEDUREsclerotherapy
In modified litothomy position patients with hemorrhoidal deasease will be treated with sclerotherapy with Aethoxysklerol
Sponsors
State Scientific Centre of Coloproctology, Russian Federation
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)
Intervention model description
Patients with hemorrhoids 2-3st will be randomized in two groups
Eligibility
Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No
Inclusion criteria
hemorrhoids 2-3st
Exclusion criteria
Acute hemorrhoids IBD psychosomatic diseases previous surgical interventions
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Reccurence rate | 12 months | reccurence of hemorroids desease |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Pain intensity | 7 days | Score representing patient's current pain intensity Minimum: 0 (no pain) Maximum: 100 (very severe pain) |
| QoL | 12 months | The SF-36 is often used as a measure of a person or population's quality of life (QOL) The SF-36 has eight scaled scores; the scores are weighted sums of the questions in each section. Scores range from 0 - 100 Lower scores = more disability, higher scores = less disability |
Countries
Russia
Outcome results
None listed